‘No more than a drop in the ocean’: this drug could end new HIV infections in Eswatini – why isn’t there enough? | Global development
In the high-stakes landscape of global HIV prevention, a paradox has emerged in Eswatini. Whereas the country stands on the precipice of eliminating latest infections, the arrival of lenacapavir—a biannual injectable pre-exposure prophylaxis (PrEP)—has been met with a supply chain bottleneck described by local health leaders as “not even a drop in the ocean.” As … Read more